21
Benjamin Oshlack, John K Masselink, Hua Pin Huang, Alfred P Tonelli: Controlled release hydrocodone formulations. Davidson Davidson & Kappel, December 19, 2002: US20020192277-A1

A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.


22
Benjamin Oshlack, Hua Pin Huang, John K Masselink, Alfred P Tonelli: Controlled release hydrocodone formulations. Purdue Pharma, Davidson Davidson & Kappel, February 17, 2011: US20110038927-A1

A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.


23
Benjamin Oshlack, Hua Pin Huang, John K Masselink, Alfred P Tonelli: Controlled release hydrocodone formulations. Purdue Pharma, Davidson Davidson & Kappel, August 13, 2009: US20090202629-A1

A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.


24
Robert P Flath, John K Masselink: Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same. Duane Morris Ny, January 22, 2009: US20090022790-A1

The present invention relates to co-extruded pharmaceutical compositions and dosage forms including an active agent, such as an opioid agonist, and an adverse agent, such as an opioid antagonist. Such compositions and dosage forms are useful for preventing or discouraging tampering, abuse, misuse or ...